Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bruce M Cohen

Showing results (111-120 of 198) with videos related to

Pageof 20
Sort By:
International Journal of Geriatric Psychiatry|April 22, 2009
31Phosphorus magnetic resonance spectroscopy study of tissue specific changes in high energy phosphates before and after sertraline treatment of geriatric depressionBrent P Forester, David G Harper, J Eric Jensen, et al.
Aging Cell|June 22, 2022
Nicotinamide riboside and caffeine partially restore diminished NAD availability but not altered energy metabolism in Alzheimer's diseaseWoo-In Ryu, Minqi Shen, Yoon Lee, et al.
Biological Psychiatry|October 17, 2017
In Vivo Brain Glycine and Glutamate Concentrations in Patients With First-Episode Psychosis Measured by Echo Time-Averaged Proton Magnetic Resonance Spectroscopy at 4TSang-Young Kim, Marc J Kaufman, Bruce M Cohen, et al.
Magnetic Resonance in Medicine|November 18, 2009
T2 relaxation time abnormalities in bipolar disorder and schizophreniaDost Ongür, Andrew P Prescot, J Eric Jensen, et al.
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|March 6, 2015
Genomewide association analyses of electrophysiological endophenotypes for schizophrenia and psychotic bipolar disorders: a preliminary reportMei-Hua Hall, Chia-Yen Chen, Bruce M Cohen, et al.
Journal of Clinical Psychopharmacology|August 29, 2012
Omega-3 fatty acid treatment, with or without cytidine, fails to show therapeutic properties in bipolar disorder: a double-blind, randomized add-on clinical trialBeth L Murphy, Andrew L Stoll, Peter Q Harris, et al.
The Journal of Clinical Psychiatry|October 19, 2017
Treatment to Enhance Cognition in Bipolar Disorder (TREC-BD): Efficacy of a Randomized Controlled Trial of Cognitive Remediation Versus Active ControlKathryn E Lewandowski, Sarah H Sperry, Bruce M Cohen, et al.
Plos Genetics|March 8, 2013
A genome-wide RNAi screen in Caenorhabditis elegans identifies the nicotinic acetylcholine receptor subunit ACR-7 as an antipsychotic drug targetTaixiang Saur, Sarah E DeMarco, Angelica Ortiz, et al.
Alcoholism, Clinical and Experimental Research|March 25, 2014
Exploring the role of central astrocytic glutamate uptake in ethanol reward in miceKaren L Smith, Catherine S John, Elizabeth I Sypek, et al.
Neuroimage. Clinical|December 16, 2021
Auditory hallucinations across the psychosis spectrum: Evidence of dysconnectivity involving cerebellar and temporal lobe regionsMelissa Hwang, Youkyung S Roh, Jessica Talero, et al.
Pageof 20

Showing results (111-120 of 198) with videos related to

Sort By:
Pageof 20
International Journal of Geriatric Psychiatry|April 22, 2009
31Phosphorus magnetic resonance spectroscopy study of tissue specific changes in high energy phosphates before and after sertraline treatment of geriatric depressionBrent P Forester, David G Harper, J Eric Jensen, et al.
Aging Cell|June 22, 2022
Nicotinamide riboside and caffeine partially restore diminished NAD availability but not altered energy metabolism in Alzheimer's diseaseWoo-In Ryu, Minqi Shen, Yoon Lee, et al.
Biological Psychiatry|October 17, 2017
In Vivo Brain Glycine and Glutamate Concentrations in Patients With First-Episode Psychosis Measured by Echo Time-Averaged Proton Magnetic Resonance Spectroscopy at 4TSang-Young Kim, Marc J Kaufman, Bruce M Cohen, et al.
Magnetic Resonance in Medicine|November 18, 2009
T2 relaxation time abnormalities in bipolar disorder and schizophreniaDost Ongür, Andrew P Prescot, J Eric Jensen, et al.
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|March 6, 2015
Genomewide association analyses of electrophysiological endophenotypes for schizophrenia and psychotic bipolar disorders: a preliminary reportMei-Hua Hall, Chia-Yen Chen, Bruce M Cohen, et al.
Journal of Clinical Psychopharmacology|August 29, 2012
Omega-3 fatty acid treatment, with or without cytidine, fails to show therapeutic properties in bipolar disorder: a double-blind, randomized add-on clinical trialBeth L Murphy, Andrew L Stoll, Peter Q Harris, et al.
The Journal of Clinical Psychiatry|October 19, 2017
Treatment to Enhance Cognition in Bipolar Disorder (TREC-BD): Efficacy of a Randomized Controlled Trial of Cognitive Remediation Versus Active ControlKathryn E Lewandowski, Sarah H Sperry, Bruce M Cohen, et al.
Plos Genetics|March 8, 2013
A genome-wide RNAi screen in Caenorhabditis elegans identifies the nicotinic acetylcholine receptor subunit ACR-7 as an antipsychotic drug targetTaixiang Saur, Sarah E DeMarco, Angelica Ortiz, et al.
Alcoholism, Clinical and Experimental Research|March 25, 2014
Exploring the role of central astrocytic glutamate uptake in ethanol reward in miceKaren L Smith, Catherine S John, Elizabeth I Sypek, et al.
Neuroimage. Clinical|December 16, 2021
Auditory hallucinations across the psychosis spectrum: Evidence of dysconnectivity involving cerebellar and temporal lobe regionsMelissa Hwang, Youkyung S Roh, Jessica Talero, et al.
Pageof 20